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A B S T R A C T
This is a retrospective study of 38 cases of infection by Babesia macropus, associated with a syndrome of
anaemia and debility in hand-reared or free-ranging juvenile eastern grey kangaroos (Macropus giganteus)
from coastal New South Wales and south-eastern Queensland between 1995 and 2013. Infection with
B. macropus is recorded for the first time in agile wallabies (Macropus agilis) from far north Queensland.
Animals in which B. macropus infection was considered to be the primary cause of morbidity had
marked anaemia, lethargy and neurological signs, and often died. In these cases, parasitised erythro-
cytes were few or undetectable in peripheral blood samples but were sequestered in large numbers within
small vessels of visceral organs, particularly in the kidney and brain, associated with distinctive clusters
of extraerythrocytic organisms. Initial identification of this piroplasm in peripheral blood smears and
in tissue impression smears and histological sections was confirmed using transmission electron mi-
croscopy and molecular analysis. Samples of kidney, brain or blood were tested using PCR and DNA
sequencing of the 18S ribosomal RNA and heat shock protein 70 gene using primers specific for piro-
plasms. The piroplasm detected in these samples had 100% sequence identity in the 18S rRNA region
with the recently described Babesia macropus in two eastern grey kangaroos from New South Wales and
Queensland, and a high degree of similarity to an unnamed Babesia sp. recently detected in three woylies
(Bettongia penicillata ogilbyi) in Western Australia.
© 2015 Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
The eastern grey kangaroo (Macropus giganteus) is one of themost
abundant large Australian macropods, with a broad distribution that
extends along the eastern seaboard andwest to inland plains. Despite
frequent contact with domestic livestock and humans in these areas,
little is known about the prevalence and impact of haemoparasite
infections in eastern grey kangaroos and the role that other
macropods may play in their maintenance and transmission in
Australia.
Babesiosis is a tick-transmitted disease caused by intraery-
throcytic protozoa of the phylum Apicomplexa and order Piro-
plasmorida, which are capable of infecting many mammalian and
some avian species. The Babesia organisms replicate within the
cytoplasm of erythrocytes, to form typically two or four merozo-
ites, which may be detected in blood samples. Although many
infections remain asymptomatic, some produce clinical disease
resulting from a severe haemolytic anaemia. Distribution of these
parasites is widespread, with members of the genus endemic in
North and South America, Europe, Asia, Africa and Australia (Taylor
et al., 2007). Some are emerging zoonotic species, with human
disease caused by Babesia divergens in Europe and by Babesia microti
in the United States (Kjemtrup and Conrad, 2000) and Australia
(Senanayake et al., 2012).
Although the occurrence of babesiosis in imported animal species,
such as cattle and dogs, has beenwell documented in Australia (Bock
et al., 2004), relatively little is known about the diversity of Babesia
spp. that are endemic to this continent. Babesia spp. have been de-
scribed in at least eight species of Australian marsupials: Babesia
thylacis in southern brown bandicoots (Isoodon obesulus) and quolls
(Dasyurus spp.) (Mackerras, 1959; O’Donoghue and Adlard, 2000;
Clark et al., 2004), Babesia tachyglossi in echidnas (Tachyglossus
aculeatus) (Backhouse and Bolliger, 1957), and an un-named Babesia
sp. in eastern grey kangaroos (Macropus giganteus) (Fletcher et al.,
2008), in woylies (Bettongia penicillata ogilbyi) (Paparini et al., 2012),
brown antechinus (Antechinus stuartii) (Cheal et al., 1976), agile
antechinus (Antechinus agilis) (O’Donoghue and Adlard, 2000) and
a Proserpine rock wallaby (Petrogale persephone) (Clark et al., 2004).
Most of these parasites were identified on evaluation of blood
smears, with their clinical significance unknown. Babesia infec-
tions in southern brown bandicoots, Gilbert’s potoroos (Potorous
gilbertii) andwoylies do not cause apparent disease (Clark et al., 2004;
Lee et al., 2009; Paparini et al., 2012). Moderate anaemia and mor-
tality have been observed in the brown antechinus (Cheal et al., 1976)
and recrudescence of Babesia infections in the male agile antechinus
is believed to contribute to post-mating mortality associated with
anaemia, haemoglobinuria, and hemosiderosis of the lung and spleen
(Barker et al., 1978).
Since 1994, a syndrome of severe anaemia and debility associ-
ated with infection by an intraerythrocytic apicomplexan protozoan
in eastern grey kangaroos has been described from the north coast
of New South Wales and south-eastern Queensland; usually, juve-
nile animals reared for variable periods by wildlife carers were
affected and developed clinical signs at 6 to 13 months of age, while
in care or soon after release (Cook et al., 1997; Ladds, 2009). Clin-
ical signs included anaemia, lethargy, inappetence and a tendency
to bleed excessively from venipuncture and tick attachment sites;
polydipsia and polyuria were reported in some animals. Small pleo-
morphic intraerythrocytic parasites were detected within peripheral
blood smears in some animals, but because the level of parasitaemia
was low and variable, diagnosis was usually confirmed by exami-
nation of histological sections and/or tissue impression smears (Cook
et al., 1997; Ladds, 2009). Recently, three cases of a similar syn-
drome were reported in eastern grey kangaroos from south eastern
Queensland and the south coast of New South Wales and a new
Babesia sp., Babesia macropus, was identified (Dawood et al., 2013).
In this paper, we report the morphological and genetic charac-
terisation of Babesia macropus, the putative cause of the disease
syndrome in eastern grey kangaroos and review the clinical and
pathological findings in 38 animals infected with this piroplasm.
We also make the first report of B. macropus infection in the agile
wallaby (Macropus agilis).
2. Materials and methods
2.1. Animals
Thirty-eight eastern grey kangaroos, diagnosed with
intraerythrocytic apicomplexan protozoan infection from 1995 to
2013, are included in this retrospective study. They originated from
an area extending from south-eastern Queensland along coastal New
SouthWales to Newcastle (Fig. 1). The captive animals were between
the ages of 6 and 19 months and included 16 males, 13 females,
and 5 of undetermined sex. The free-ranging animals were three
young-at-foot and one adult. Sick or dead kangaroos or samples col-
lected from them were examined at the Australian Registry of
Wildlife Health (ARWH), Mosman, New South Wales (10 animals
in 2012; 3 animals in 2013); the Biosecurity Sciences Laboratory
(BSL) in Coopers Plains, Queensland (2 animals in 2009; 2 animals
in 2012); or the Regional Veterinary Laboratory Wollongbar (RVL-
W), New South Wales (21 animals between 1995 and 2005).
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Three agile wallabies from the Townsville region (Fig. 1) died
while in care of wildlife rehabilitators (one in 2009 and two in 2013)
and were examined at the School of Veterinary and Biomedical Sci-
ences, James Cook University, Townsville, Queensland.
2.2. Haematology
Bloodpreserved in EDTAwas examined from32 eastern grey kan-
garoos andone agilewallaby. Complete blood countswere conducted
when possible, and blood films from each animal were stained with
Giemsa and examined under light microscopy.
2.3. Pathology
Of the 38 eastern grey kangaroos in this study, necropsies were
conducted on 31 that had died or were euthanised due to declin-
ing health. At necropsy, a range of tissue samples, usually including
kidney, brain, spleen, liver, heart, lung and bone marrow, was col-
lected and fixed in 10% neutral buffered formalin for histological
examination. From some of these cases, fresh tissues, usually
including kidney and brain, spleen and bonemarrow, were also avail-
able for cytological evaluation, microbial culture, toxicological testing,
and molecular examination.
Necropsies were conducted on the three agile wallabies, and
tissue samples, usually including kidney, spleen, liver, heart, lung,
stomach and brain, were fixed in 10% neutral buffered formalin for
histological examination.
2.4. Cytology
Impression smears from kidney, liver, brain, spleen and bone
marrow were made at necropsy of many of the eastern grey kan-
garoos and one agile wallaby, and were stained with Giemsa or Diff-
Quik for microscopic evaluation.
2.5. Histopathology
The formalin-fixed tissues were processed routinely and em-
bedded in paraffin wax. Sections were stained with haematoxylin
and eosin and Giemsa.
Fig. 1. Map showing the distribution of the 38 cases of Babesia infection in eastern grey kangaroos in coastal New South Wales and southeastern Queensland over the period
1995–2013. Insert also shows the two locations of the three cases identified in agile wallabies in northern Queensland in 2009 and 2013. The locations of cases were
converted to GPS coordinates and mapped using GPS Visualizer on 21/05/2014 (www.gpsvisualizer.com).
270 S.L. Donahoe et al./International Journal for Parasitology: Parasites and Wildlife 4 (2015) 268–276
2.6. Ancillary testing
To determine whether the clinical signs were attributable to
babesiosis, another aetiologic agent or a multifactorial process
tests were conducted on tissues collected, and stored for several
weeks at −80°C, from seven eastern grey kangaroos examined at
the ARWH. Lung and liver samples from each animal were sub-
jected to aerobic, anaerobic, and fungal culture, using MacConkey
agar, Columbia blood agar, Anaerobe agar, and Sabouraud broth
with antibiotics (Oxoid, distributed by Thermo Fisher, Adelaide,
South Australia). Formalin-fixed, paraffin-embedded brain and kidney
were submitted for immunohistochemistry using polyclonal anti-
body against Toxoplasma gondii andNeospora caninum. Brain samples
were submitted for viral culture and PCR to detect Tammar orbivirus
(Rose et al., 2012). Liver tissues were subjected to thin layer chro-
matography for the identification of anticoagulants (warfarin,
coumatetralyl, difenacoum, bromadiolone, brodifacoum and
flocoumafenpindone and diphacinone) and were analysed for con-
centrations of Hg (method 04-006, US EPA 200.7 Revision 5.0
“Trace elements in water, solids and biosolids by inductively coupled
plasma-atomic emission spectrometry”), Cu, Zn, As, Pb, Se, and Cd
(method 04–016, US EPA method 200.8 Revision 5.4 “Trace ele-
ments in water, solids and biosolids by inductively coupled plasma-
mass spectrometry”).
2.7. Transmission electron microscopy
Brain and kidney tissues of two animals (from ARWH and RVL-
W) were formalin-fixed and subsequently processed with
glutaraldehyde and osmium tetroxide before infiltration and em-
bedding in resin. Ultrathin sections were stained with uranyl acetate
and lead citrate and examined in a JEOL 1010 or a Philips CM120
transmission electron microscope.
2.8. DNA extraction, amplification protocols, and sequencing
Samples of fresh brain, kidney or blood from nine eastern grey
kangaroos from ARWH (2012 and 2013 cases), five from the RVL-W
(1996, 1997, 1998, 1998 and 2002 cases) and two from the BSL
(2012 cases), and from one agile wallaby (one of the 2013 cases)
were collected at necropsy, frozen at −20°C or −80°C and subse-
quently used for DNA extraction and sequencing undertaken from
2012 onwards. Twenty milligrams of kidney, brain or 50 μl blood
was pre-lysed for 4 hours at 55°C and then extracted using the
PureLink Genomic DNA kit (Life Technologies Australia, Victoria,
New South Wales). Samples of formalin-fixed, paraffin-embedded
kidney from the other two agile wallabies (2009 case and second
2013 case) were similarly processed. The DNA was then used to
amplify regions of the 18S ribosomal RNA (18S rRNA) gene and
heat shock protein 70 (hsp70) gene using primers that are specific
to Piroplasmida. A 934 bp fragment of the 18S rRNA gene was
amplified using the primers BTF1 5′-GGCTCATTACAACAGTTATAG-
3′ and BTR1 5′-CCCAAAGACTTTGATTTCTCTC-3′ (Jefferies et al., 2007).
A second locus, a ~ 740 bp fragment of the hsp70 gene, was am-
plified using primers targeted to the region 255–903 hsp70F1
5′-CATGAAGCACTGGCCHTTCAA-3′ and hsp70R1 5′-GCNCKGCTGAT
GGTGGTGTTG-3′ (Soares et al., 2011). In all cases, appropriate
positive and water negative controls were used to validate the
results. PCR products were then submitted for forward and reverse
Sanger sequencing by the Australian Genome Research Institute.
In each case, the reverse sequences returned were reverse comple-
mented, matched to the forward sequences and used to construct
a composite region of 850 bp for the 18S rRNA gene and of 631 bp
for the hsp70 gene for phylogenetic analysis.
2.9. Phylogenetic analysis
Initial nucleotide BLAST results for both the 18S rRNA and hsp70
gene sequences against the GenBank nucleotide database showed
greatest similarity to sequences from Babesia spp. For phyloge-
netic analysis, a range of sequences of Babesia spp. and closely related
Theileria spp. was retrieved from GenBank along with a represen-
tative from other apicomplexan parasites for use as outliers. Fasta
files containing all the sequences were imported into MEGA6 which
was used for alignment, determination of the best fit model and phy-
logenetic tree building (Tamura et al., 2011). The sequences were
aligned using CLUSTAL W (Larkin et al., 2007). The best-fit substi-
tution models were selected based on the lowest Bayesian
Information Criterion (BIC) score (Tamura-Nei). Neighbor-Joining (NJ)
trees were constructed within the program. Bootstrap values were
determined for 500 replicates to test tree reliability.
3. Results
3.1. Clinical findings
Clinical changes detected in the 38 eastern grey kangaroos in-
cluded anaemia, lethargy and neurological signs, including
depression, ataxia, bruxism and ocular deficits (persistent mydria-
sis, loss of pupillary light reflex and a variable menace response).
Some animals were chronic poor doers, while others were in fair
to good body condition with only a recent history of debilitation.
Additional signs reported in some animals included bleeding from
venepuncture sites, polydipsia and polyuria. Animals with a strongly
regenerative anaemia were reported to have responded to empir-
ical treatment with imidocarb.
Two of the three agile wallabies had been in care with wildlife
rehabilitators for 6 months and had been clinically normal until sud-
denly appearing depressed and inappetent for a day and dying
overnight. The third wallaby was in care for several months in 2013
before showing depression associated with a severe regenerative
anaemia. This animal died three days after treatment with imidocarb.
3.2. Haematology and clinical chemistry
The haematological examination of 33 animals revealed a PCV
range between 5 and 45%, whereas normal values for this species
range between 39 and 51% (ISIS, 2002). Blood films frommacropods
with a PCV of <25% had evidence of anisocytosis and polychroma-
sia, which was considered consistent with a regenerative anaemia.
Within peripheral blood smears from 14 eastern grey kangaroos and
one agile wallaby, usually less than 5% of erythrocytes contained
pyriform, oval, fusiform or irregularly shaped protozoan zoites, 1
to 5 μm in width or length and morphologically consistent with
Babesia spp. (Table 1); individual erythrocytes contained usually two
to four, but occasionally up to 16 zoites (Fig. 2A). Other variable, clin-
ical pathological findings included thrombocytopoenia, neutropoenia,
hyperamylasemia, decreased total serum protein, hypoalbuminaemia,
hypoglobulinaemia, elevated blood urea nitrogen and elevated total
serum bilirubin.
3.3. Pathology
Themost common necropsy findings included variable body con-
dition, ranging from normal to emaciated, diffuse pallor of the carcass
and visceral organs, thin watery blood that was slow to clot, wide-
spread petechiae, ecchymoses and tissue oedema, splenomegaly and
occasionally generalised lymphadenomegaly.
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3.4. Cytology
In the eastern grey kangaroos, two distinctive forms of the Babesia
organism were identifiable in tissue impression smears, particu-
larly of kidney and brain. There were large numbers of intact
erythrocytes containing usually two or four protozoan zoites within
their cytoplasm and many clusters of extracellular protozoan zoites
(Fig. 2B,C). These findings were in contrast to the very small numbers
of parasitised erythrocytes detected in peripheral blood smears. The
organisms ranged from 1 to 5 μm in diameter and were pyriform,
oval or fusiform, with hypochromic cytoplasm and a single baso-
philic eccentric nucleus.
3.5. Histopathology
In histological sections, the lumens of small-calibre blood vessels
in many organs contained large numbers of parasitised erythro-
cytes and also distinctive clusters, up to 25 μm in diameter, of zoites
within a pink coagulum. Some of these protozoal clusters ap-
peared to be within or adherent to degenerating erythrocytes. In
the eastern grey kangaroos, these changes were most prominent
within the capillaries of the renal glomerular tufts and the brain
(Fig. 2D). In the agile wallabies, organisms were detected in capil-
laries of the renal cortex, heart, and stomach but not in the two brains
examined histologically. In none of the specimens examined was
there evidence of inflammation associated with this intravascular
sequestration of parasitised erythrocytes or with the intravascu-
lar clusters of extraerythrocytic organisms.
Table 1
Summary of Babesia infections detected in 38 eastern grey kangaroos (Macropus
giganteus) and three agile wallabies (Macropus agilis) reviewed in this study (1995–
2013). The failure to detect Babesia organisms in peripheral blood smears of some
animals with histological evidence of infection reflects the low and variable level
of parasitaemia.
No. of animals Babesia infection result
Histopathology Haematology PCR
Eastern grey kangaroos
5 POS POS POS
9 POS NEG POS
2 POS NT POS
2 POS POS NT
9 POS NEG NT
4 POS NT NT
7 NT POS NT
38 total 31 tested 32 tested 16 tested
Agile wallabies
1 POS POS POS
1 POS NT POS*
1 POS NT NEG*
3 total 3 tested 1 tested 3 tested
PCR: PCR test for Babesia specific 18s rRNA and hsp70 gene sequences.
POS: Positive.
NEG: Negative.
NT: Not tested.
* These two PCR tests were on formalin-fixed, paraffin-embedded samples. The
sample that tested negative (2009 case) had been exposed to prolonged formalin
fixation.
Fig. 2. Photomicrographs showing the forms of Babesia seen in cytological preparations and tissue sections in macropods. (A) Agile wallaby. Giemsa stained peripheral blood
smear showing extraerythrocytic zoites (thin arrow) and merozoites (thick arrow) within an intact erythrocyte. (B) Eastern grey kangaroo. Diff-Quik-stained renal impres-
sion smear demonstrating 2 or 4 merozoites within intact erythrocytes (thick arrows) and clusters of extraerythrocytic zoites (thin arrows). (C) Eastern grey kangaroo. Diff-
Quik-stained brain squash preparation showing large clusters of intravascular zoites (arrows). (D) Eastern grey kangaroo. H&E stained section of kidney glomerulus showing
merozoites within intact erythrocytes (thick arrows) and as large extraerythrocytic clusters of zoites (thin arrows). All scale bars = 20 μm.
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In cases where Babesia-associated anaemia was considered the
primary cause of clinical disease, other non-specific histological
changes included pulmonary congestion and oedema, bone marrow
hyperplasia and lymphoid hyperplasia in peripheral lymph nodes.
3.6. Electron microscopy
Transmission electron microscopic examination of kidney and
brain revealed intra and extraerythrocytic zoites 714–1530 nm in
size (Fig. 3A,B). They were small eukaryotic unicellular organisms
with well-defined internal structures consistent with apicomplexan
piroplasms, including a membrane bound nucleus, electron dense
ellipsoidal micronemes, and a cell membrane subtended by micro-
tubules when mature (forming a pellicle) (Fig. 3B). Immature
parasites appeared as undifferentiated merozoites (simple walls and
few organelles) located within erythrocytes which otherwise ap-
peared normal, with distinctmembranes and filledwith homogenous
electron-dense haemoglobin. Mature parasites had developed more
conspicuous internal structures (subpellicular microtubules and
micronemes), while the parasitised erythrocytes exhibited signs of
progressive degeneration, including irregular cell outlines, indis-
tinct membranes, and depletion and electron opacity of cytoplasmic
haemoglobin. Extraerythrocytic aggregations of zoites were nu-
merous within the lumens of capillaries and, in some images, these
clumps appeared to be loosely surrounded by membranous cellu-
lar remnants, the likely fragments of ruptured erythrocytes (Fig. 3C).
3.7. Molecular studies
All 16 eastern grey kangaroos and two of the three agile walla-
bies with histological evidence of infection were positive on PCR
for the Babesia specific 18s rRNA and hsp70 gene sequences; the
sample from the 2009 agile wallaby case had been exposed to
prolonged formalin fixation and yielded DNA of poor quality and
a negative result on PCR (Table 1). The 850 bp DNA sequence prod-
ucts for the 18S rRNA gene from the 16 eastern grey kangaroo
samples were identical in sequence. A nucleotide BLAST search
performed in January 2013 with this 18S rRNA gene sequence
revealed no identical sequence in the public databases to this
parasite. The most closely related sequences with 97% sequence
identity were from a novel Babesia spp. recently detected in wild
woylies in Western Australia (Fig. 4). Since this comparison was
done, an identical sequence has been submitted and published for
B. macropus from two eastern grey kangaroos from Queensland
and New South Wales (Dawood et al., 2013). In contrast, analysis
of the 850 bp DNA sequence product for the 18S rRNA gene from
the blood sample of a 2013 agile wallaby case showed that al-
though highly related to the eastern grey kangaroo sequence, there
were significant differences, with 98% sequence identity across
this region. This difference was confirmed in the second 2013
agile wallaby case using a shorter sequence from this gene taken
from DNA extracted from formalin-fixed, paraffin-embedded ma-
terial. The 631 bp DNA sequence products for the hsp70 gene
from all but two of the 16 eastern grey kangaroo samples were
identical in sequence; a sample collected in 1998 (RVL-W) and
one in 2013 (ARWH) showed a < 0.5% difference (3 bases and 2
bases respectively) (Fig. 5). In comparison, analysis of the 631 bp
DNA sequence product for the hsp70 gene from the blood sample
of the 2013 agile wallaby case showed ~5% difference from the
eastern grey kangaroo sequences (Fig. 5). DNA from the formalin-
fixed, paraffin-embedded material from the second wallaby case
in 2013 was not of sufficient quality to sequence this locus.
3.8. Microbiology, parasitology, virology and toxicology
Amongst the 32 eastern grey kangaroos with histological evi-
dence of Babesia infection, concurrent coccidiosis in three cases and
amyloidosis in one case were found; babesiosis was not consid-
ered the primary cause of morbidity in these four animals. No other
viral, bacterial, fungal, protozoal or helminth agent was detected
that would account for the disease syndrome in the remaining
macropods examined.
4. Discussion
This retrospective study included recent molecular phylogenic
analysis of fragments of 18S rRNA and hsp70 genes amplified by
PCR on brain, kidney and/or blood samples from 16 eastern grey
kangaroos diagnosed with histological evidence of piroplasm in-
fection between 1995 and 2013. Phylogenetic analysis of 18S rRNA
sequence products identified this organism as Babesia macropus, re-
cently described in an eastern grey kangaroo from south-eastern
Queensland and in another from the south coast of New SouthWales
Fig. 3. Transmission electron micrographs showing the intravascular location and structure of Babesia organisms in the kidney and brain of eastern grey kangaroos. (A)
Kidney, the cytoplasm of two adjacent erythrocytes contains Babesia merozoites (arrows) with a membrane-bound nucleus (N) and cytoplasm containing polymorphic vacu-
oles and some electron dense particles (C) (scale bar = 1.0 μm). (B) Brain, adjacent to an intact erythrocyte and the nucleus of an endothelial cell is a cluster of extraerythrocytic
Babesia organisms containing electron dense micronemes and developing pellicles (arrows) (scale bar = 2.0 μm). (C) Brain, within the capillary lumen is a cluster of eight or
nine extraerythrocytic organisms (thick arrow) and a distorted erythrocyte (thin arrow) containing four intracytoplasmic parasites (scale bar = 5.0 μm).
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(Dawood et al., 2013), and which is closely related to recently-
described Babesia isolates from woylie.
Our findings that gene fragment sequences were identical in all
16 animals for 18S rRNA and in 14 of 16 animals for hsp70 (with
a < 0.5% difference of only 3 bases and 2 bases respectively in 2
animals) confirm the genetic uniformity of B. macropus infecting
eastern grey kangaroos during the period of the study.
The clinical signs, gross and light microscopic changes, and par-
asite morphology in this study were consistent with the syndrome
of severe anaemia associated with a suspected apicomplexan
haematozoan infection in juvenile, hand-reared eastern grey kan-
garoos, first recognised in 1994 on the north coast of New South
Wales (Cook et al., 1997; Ladds, 2009). The distinctive clusters of
extraerythrocytic organisms viewed histologically within capillar-
ies of the brain, kidney and other organs of affected eastern grey
kangaroos were initially interpreted as being located either within
the vessel lumen or possibly within endothelial cells, the latter lo-
cation not being a feature of the life cycle of Babesia species (Homer
et al., 2000). Definitive identification of the organism as a new species
of Babesia was delayed until the recent molecular genetic studies
characterised it as B. macropus. Further histological, cytological and
electron microscopic examinations suggested that the distinctive
clusters of extraerythrocytic organisms within capillaries are most
likely to be zoites of B. macropus released from degenerating, se-
questered erythrocytes.
Clinical features of disease associated with B. macropus are con-
sistent with those described for babesiosis in other species and
include anaemia, thrombocytopaenia, leukopaenia, emaciation, leth-
argy, ill-thrift, splenomegaly, lymphadenomegaly, and haemorrhage
and oedema in multiple tissues (Homer et al., 2000; Solano-Gallego
and Baneth, 2011; Schnittger et al., 2012). Anaemia, the most con-
sistent clinical sign in original reports of this syndrome in eastern
grey kangaroos, was observed to varying degrees in the cases re-
viewed, and the detection of anisocytosis and polychromasia in blood
smears and bone marrow hyperplasia indicated that the anaemia
was regenerative. The pathogenesis of haemolytic anaemia in ba-
besiosis has not been fully elucidated, but may involve direct
erythrocyte damage by replicating parasites, immune-mediated
mechanisms, or a combination thereof (Solano-Gallego and Baneth,
2011).
Definitive diagnosis of babesiosis in live macropods is cur-
rently hampered by the lack of a sensitive laboratory test. A
provisional clinical diagnosis based on history, clinical signs and
haemogram results can be confirmed in some cases by identifica-
tion of intraerythrocytic organisms in peripheral blood smears.
However, the numbers of parasitised erythrocytes detectable in
blood collected from veins are low and variable; evaluation of
capillary blood (in tail-tip or ear-tip blood smears), as is recom-
mended for diagnosis of Babesia bovis infection in live cattle (Bock
et al., 2004), may increase the chance of detecting parasitised
Fig. 4. Phylogenetic tree of 18S ribosomal RNA (18S rRNA) gene sequences of eastern grey kangaroo and agile wallaby Babesia and other piroplasms that are in the GenBank
nucleotide database. For each sequence, the GenBank GI number is followed by the species name. The representative Babesia isolates from eastern grey kangaroos and an
agile wallaby in this study are shown with a Ë and a ♦ respectively. Evolutionary history was inferred using the Maximum Likelihood method based on the Tamura 3-parameter
model. The tree with the highest log likelihood (−1820.5242) is shown. Initial tree for the heuristic search was obtained automatically as follows. When the number of common
sites was <100 or less than one fourth of the total number of sites, the maximum parsimony method was used; otherwise, BIONJ method with MCL distance matrix was
used. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. The scale bar represents the number of substitutions per nucleotide.
All positions containing gaps and missing data were eliminated. Evolutionary analyses were conducted in MEGA6 (Tamura et al., 2011).
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erythrocytes circulating in peripheral blood of live macropods.
Confirmation of infection is usually based on cytological or histo-
logical examination of tissues collected at necropsy. Examination
of stained impression smears of brain and kidney is an efficient
and rapidmethod of detecting this organism at the time of necropsy.
The pathogenesis of the neurological signs reported in some
eastern grey kangaroos may be related to the intravascular seques-
tration of parasitised erythrocytes and distinctive clusters of
extraerythrocytic organisms within the central nervous system.
Putative pathogenic mechanisms include those reported for cere-
bral babesiosis and cerebral malaria, specifically hypoxic injury
and/or inflammatory cytokine release caused by sludging of
parasitised erythrocytes in brain capillaries (obstructive seques-
tration) and possible endothelial damage (Schetters and Eling,
1999). Some species of Babesia such as B. bovis in cattle (Canto
et al., 2006), Babesia lengau in cats (Bosman et al., 2013) and
Brucella canis in dogs (Jacobson, 2006) can cause such cerebral
localisation of infection, which is associated with a poor progno-
sis (Canto et al., 2006; Jacobson, 2006). Certain species and strains
of Babesia can alter the physiology of the infected erythrocyte and
increase its adherence to other cells, including endothelial cells
(Wright, 1972; O’Connor and Allred, 2000).
Suggested treatment in macropods with babesiosis has in-
cluded provision of supportive care, including fluid therapy,
nutritional and thermal support, and blood transfusions (Vogelnest
and Portas, 2008). The reported response by some infected, anaemic
animals to parenteral treatment with imidocarb remains anec-
dotal and unevaluated (Cook et al., 1997; Vogelnest and Portas, 2008).
To date, all identified vectors of Babesia spp. are ticks, which trans-
mit infection via their saliva during feeding. Studies are currently
underway to determine the vector(s) for B. macropus in macropods;
Haemaphysalis spp. and Ixodes spp. seem likely candidates.
This first report of B. macropus infection in another large mac-
ropod, the agile wallaby, identified a similar pathological phenotype
to infection in the eastern grey kangaroo, but in a different geo-
graphic location (Townsville in Queensland). Although there were
some sequence differences within the Babesia genetic loci encod-
ing 18S rRNA and hsp70 in the agile wallaby compared with the
eastern grey kangaroo samples, the phylogenetic analysis showed
they were highly related and probably represent natural variation
within the B. macropus species. This suggests that B. macropus, as
seen with other recently characterised haematoprotozoans in Aus-
tralianmacropods, may infect a range of native fauna, althoughmost
infectionsmay be subclinical (Dougall et al., 2009; Botero et al., 2013).
This study highlights the importance of molecular phylogenic anal-
ysis for distinguishing Babesia spp. detected in Australianwildlife.Most
zoonotic Babesia recognised overseas are maintained in wildlife res-
ervoirs, andmolecular characterisation of Babesia frompotentialwildlife
reservoirs andvectors is encouraged to allowcomparisonwith anynovel
Babesia detected in a human patient (Yabsley and Shock, 2013).
Fig. 5. Phylogenetic tree of heat shock protein 70 (hsp70) gene sequences of eastern grey kangaroo and agile wallaby Babesia and other piroplasm hsp70 sequences in the
GenBank nucleotide database. For each sequence, the GenBank GI number is followed by the species name. The representative Babesia isolates from eastern grey kangaroos
and an agile wallaby in this study are shown with a Ë and a ♦ respectively. The evolutionary history was inferred using the Maximum Likelihood method based on the Tamura-
Nei model (Tamura and Nei, 1993). The tree with the highest log likelihood (−6290.3774) is shown. Initial tree for the heuristic search was obtained automatically as follows.
When the number of common sites was <100 or less than one fourth of the total number of sites, the maximum parsimony method was used; otherwise, BIONJ method
with MCL distance matrix was used. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. The scale bar represents the number
of substitutions per nucleotide. All positions containing gaps and missing data were eliminated. There are limited data available on this locus within the public data
repositories and as such there is some lack of consistency with the 18S ribosomal RNA tree.
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Following this characterisation of B. macropus infection in eastern
grey kangaroos and agile wallabies, further studies are required to
generate sensitive diagnostic tests for detection of infection in live
animals and to improve our understanding of the epidemiology, in-
cluding reservoir hosts, vector(s) and geographic distribution, of this
organism, and the pathogenesis of infection in macropods.
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